What's in this set
AngelMatch's pitch deck database currently has one clinical trials pitch deck: Leapcure's seed deck, which raised $125K in 2016. Leapcure builds tools for clinical trial patient recruitment, engagement, and retention, and the same deck is also tagged to the healthcare pitch deck filter, since trial recruitment sits inside the wider healthcare category. One deck is not enough to show a spread of rounds, years, or raise sizes, so treat this page as a starting point rather than a full survey of the category, and check the healthcare filter for more examples in the meantime.
What investors look for in a clinical trials pitch deck
Clinical trials is an infrastructure and services category more than a therapeutics category, and investors read decks in it differently than they read a drug deck. Two things carry particular weight here.
- Regulatory and data handling literacy. A trial recruitment or engagement product touches protected health information and IRB-governed processes, so a deck needs to show the founders understand informed consent and patient privacy requirements, not just the product screens. Leapcure's seed deck is built around exactly this kind of oversight, since patient recruitment tools sit close to the trial protocol itself.
- Enrollment economics instead of generic user growth. Trial delays cost sponsors real money, so a strong deck in this category quantifies time to fill a trial arm, cost per patient screened, or sites onboarded, rather than leaning on signup counts the way a consumer product deck would.
- Named relationships with sponsors, CROs, or trial sites. The buyer here is usually a pharmaceutical company, a contract research organization, or a site network rather than an individual consumer, so investors want proof that at least one of those relationships already exists. Leapcure's $125K raise is a reminder that early decks in this space often close a small first check while those relationships are still forming.
AngelMatch's investor database lists 2,700+ investors under the clinical trials market, which is a useful next stop once you have studied Leapcure's raise: find clinical trials investors who back trial infrastructure. Leapcure's $125K seed round shows that even a small first check is enough to get a clinical trials company into this database, so a tightly scoped deck matters more than a large ask at this stage.
Healthcare pitch decks
